Location: Home
  • search
  • go
  • Relate News
  • 4/8/2024NMPA Announces OTC Switch of Bismuth Potassium Citrate Capsules
  • 4/5/2024Ascletis Drops FXR Agonist ASC42 After Disappointing Phase II Results
  • 4/5/2024China Continues to Crackdown on Monopoly and Unfair Market Practices i...
  • 4/5/2024UB and 7th Affiliated Hospital of SYU Launch A Joint Clinical Research...
  • 4/5/2024Drug R&D and Product Registration News Digest April 2024 (1)
  • 4/5/2024Recent Official Changes and Executive Moves
  • 4/5/2024Foreign Investors Fled Chinese Biotech After the Pandemic. They Still ...
  • 4/4/2024Rohto and Mitsui to Buy TCM Company for $590M
  • 4/3/2024Genmab A/S to Acquire ADC Developer ProfoundBio for $1.8B Cash
  • 4/3/2024NMPA Issues Announcement on the Implementation of Electronic Drug Regi...
  • 4/3/2024NMPA Issues the Principles and Procedures for Exploratory Studies of D...
  • 4/3/2024What To Know About Jiyoutai - China's First Potential Ozempic Challeng...
  • 4/3/2024Chinese ADC Investment Boom in Question With China-U.S. R&D Relations ...
  • 4/2/2024NHC Holds the 2024 National Drug Administration Work Conference
  • 4/2/2024CDE Solicits Comments on the Pharmaceutical Self-Assessment Report for...
  • 4/2/2024Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...
  • 4/2/2024Takeda's Drive: Elevating Chinese Clinical Trials and Global Health
  • 4/1/2024NMPA Announces Package Insert Revision of Metronidazole Injection and ...
  • 4/1/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trial D...
  • 4/1/2024Congress Targets Biotech Suppliers for Pentagon Watchlist Amid China S...
  • 4/1/2024CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...
  • 3/30/2024JPO Launches Follow-On Procurement for the National Level Insulin VBP ...
  • 3/30/2024Drug R&D and Product Registration News Digest March 2024 (4)
  • 3/30/2024Financial-related Company News Digest (March 2024)
  • 3/30/2024Recent Official Changes and Executive Moves
  • 3/30/2024NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...
  • 3/29/2024WuXi AppTec Shared US Client's Data with Beijing (Reuters)
  • 3/29/2024Small Biotechs Reveal Reliance on Chinese CDMOs (BioCentury)
  • 3/29/2024NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...
  • 3/27/2024U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (WSJ...
  • Page:3/709 Total number of articles:21268: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group